Clinical Trial Update: Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of BMS-582949 in rheumatoid arthritis patients on methotrexate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BMS-582949

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED